REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 20th, 2015 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 19, 2014 among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
COMPOSITE UNIT PURCHASE AGREEMENT BY AND AMONG BIOSIG TECHNOLOGIES, INC. AND EACH PURCHASER IDENTIFIED ON THE SIGNATURE PAGES HERETOUnit Purchase Agreement • February 20th, 2015 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of December 19, 2014 by and among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK A WARRANT BIOSIG TECHNOLOGIES, INC.BioSig Technologies, Inc. • February 20th, 2015 • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK A WARRANT (the “A Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on July 31, 2015 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “A Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this A Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK B WARRANT BIOSIG TECHNOLOGIES, INC.BioSig Technologies, Inc. • February 20th, 2015 • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK B WARRANT (the “B Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on March 31, 2020 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “B Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this B Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
